BRIGHT MINDS BIOSCIENCES INC. Sales And Marketing Expense
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Sales And Marketing Expense of CAD 41.60 thousand for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2024-12-31
| Period end | Sales And Marketing Expense 4 month | Sales And Marketing Expense 12 month |
|---|---|---|
| 2024-09-30 | 41.60K CAD 20-F · filed 2024-12-31 | |
| 2023-09-30 | 119.42K CAD 20-F · filed 2024-12-31 | |
| 2022-09-30 | 551.86K CAD 20-F · filed 2024-12-31 | |
| 2021-09-30 | 852.15K CAD 20-F · filed 2023-12-29 | |
| 2020-09-30 | 9.62K CAD 20-F · filed 2022-12-29 | |
| 2019-09-30 | 0.00 CAD 20-F/A · filed 2022-01-18 |